These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 14520384)
21. Michigan's next wave of biopharmaceutical entrepreneurship. Kerppola R; van de Walle M; Surine S Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575 [No Abstract] [Full Text] [Related]
22. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs. Rinaldi A EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923 [TBL] [Abstract][Full Text] [Related]
23. How the EU can fund your company. Gilbert N Nat Biotechnol; 2007 Jan; 25(1):21-4. PubMed ID: 17294566 [No Abstract] [Full Text] [Related]
24. Companies jostle for access to public markets. Bouchie A Nat Biotechnol; 2003 Dec; 21(12):1413-4. PubMed ID: 14647309 [No Abstract] [Full Text] [Related]
25. Where the money is. Fitzgerald M Nat Biotechnol; 2006 Mar; 24(3):240-2. PubMed ID: 16525370 [No Abstract] [Full Text] [Related]
29. US venture capital for biotechnology. Dibner MD; Trull M; Howell M Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144 [No Abstract] [Full Text] [Related]
30. Convincing a venture capitalist to invest in your idea. Dooley JF; Dooley JF Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980 [No Abstract] [Full Text] [Related]